Cargando…
Optic Nerve Diffusion Tensor Imaging after Acute Optic Neuritis Predicts Axonal and Visual Outcomes
BACKGROUND: Early markers of axonal and clinical outcomes are required for early phase testing of putative neuroprotective therapies for multiple sclerosis (MS). OBJECTIVES: To assess whether early measurement of diffusion tensor imaging (DTI) parameters (axial and radial diffusivity) within the opt...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873392/ https://www.ncbi.nlm.nih.gov/pubmed/24386285 http://dx.doi.org/10.1371/journal.pone.0083825 |
_version_ | 1782297105155489792 |
---|---|
author | van der Walt, Anneke Kolbe, Scott C. Wang, Yejun E. Klistorner, Alexander Shuey, Neil Ahmadi, Gelareh Paine, Mark Marriott, Mark Mitchell, Peter Egan, Gary F. Butzkueven, Helmut Kilpatrick, Trevor J. |
author_facet | van der Walt, Anneke Kolbe, Scott C. Wang, Yejun E. Klistorner, Alexander Shuey, Neil Ahmadi, Gelareh Paine, Mark Marriott, Mark Mitchell, Peter Egan, Gary F. Butzkueven, Helmut Kilpatrick, Trevor J. |
author_sort | van der Walt, Anneke |
collection | PubMed |
description | BACKGROUND: Early markers of axonal and clinical outcomes are required for early phase testing of putative neuroprotective therapies for multiple sclerosis (MS). OBJECTIVES: To assess whether early measurement of diffusion tensor imaging (DTI) parameters (axial and radial diffusivity) within the optic nerve during and after acute demyelinating optic neuritis (ON) could predict axonal (retinal nerve fibre layer thinning and multi-focal visual evoked potential amplitude reduction) or clinical (visual acuity and visual field loss) outcomes at 6 or 12 months. METHODS: Thirty-seven patients presenting with acute, unilateral ON were studied at baseline, one, three, six and 12 months using optic nerve DTI, clinical and paraclinical markers of axonal injury and clinical visual dysfunction. RESULTS: Affected nerve axial diffusivity (AD) was reduced at baseline, 1 and 3 months. Reduced 1-month AD correlated with retinal nerve fibre layer (RNFL) thinning at 6 (R=0.38, p=0.04) and 12 months (R=0.437, p=0.008) and VEP amplitude loss at 6 (R=0.414, p=0.019) and 12 months (R=0.484, p=0.003). AD reduction at three months correlated with high contrast visual acuity at 6 (ρ = -0.519, p = 0.001) and 12 months (ρ = -0.414, p=0.011). The time-course for AD reduction for each patient was modelled using a quadratic regression. AD normalised after a median of 18 weeks and longer normalisation times were associated with more pronounced RNFL thinning and mfVEP amplitude loss at 12 months. Affected nerve radial diffusivity (RD) was unchanged until three months, after which time it remained elevated. CONCLUSIONS: These results demonstrate that AD reduces during acute ON. One month AD reduction correlates with the extent of axonal loss and persistent AD reduction at 3 months predicts poorer visual outcomes. This suggests that acute ON therapies that normalise optic nerve AD by 3 months could also promote axon survival and improve visual outcomes. |
format | Online Article Text |
id | pubmed-3873392 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-38733922014-01-02 Optic Nerve Diffusion Tensor Imaging after Acute Optic Neuritis Predicts Axonal and Visual Outcomes van der Walt, Anneke Kolbe, Scott C. Wang, Yejun E. Klistorner, Alexander Shuey, Neil Ahmadi, Gelareh Paine, Mark Marriott, Mark Mitchell, Peter Egan, Gary F. Butzkueven, Helmut Kilpatrick, Trevor J. PLoS One Research Article BACKGROUND: Early markers of axonal and clinical outcomes are required for early phase testing of putative neuroprotective therapies for multiple sclerosis (MS). OBJECTIVES: To assess whether early measurement of diffusion tensor imaging (DTI) parameters (axial and radial diffusivity) within the optic nerve during and after acute demyelinating optic neuritis (ON) could predict axonal (retinal nerve fibre layer thinning and multi-focal visual evoked potential amplitude reduction) or clinical (visual acuity and visual field loss) outcomes at 6 or 12 months. METHODS: Thirty-seven patients presenting with acute, unilateral ON were studied at baseline, one, three, six and 12 months using optic nerve DTI, clinical and paraclinical markers of axonal injury and clinical visual dysfunction. RESULTS: Affected nerve axial diffusivity (AD) was reduced at baseline, 1 and 3 months. Reduced 1-month AD correlated with retinal nerve fibre layer (RNFL) thinning at 6 (R=0.38, p=0.04) and 12 months (R=0.437, p=0.008) and VEP amplitude loss at 6 (R=0.414, p=0.019) and 12 months (R=0.484, p=0.003). AD reduction at three months correlated with high contrast visual acuity at 6 (ρ = -0.519, p = 0.001) and 12 months (ρ = -0.414, p=0.011). The time-course for AD reduction for each patient was modelled using a quadratic regression. AD normalised after a median of 18 weeks and longer normalisation times were associated with more pronounced RNFL thinning and mfVEP amplitude loss at 12 months. Affected nerve radial diffusivity (RD) was unchanged until three months, after which time it remained elevated. CONCLUSIONS: These results demonstrate that AD reduces during acute ON. One month AD reduction correlates with the extent of axonal loss and persistent AD reduction at 3 months predicts poorer visual outcomes. This suggests that acute ON therapies that normalise optic nerve AD by 3 months could also promote axon survival and improve visual outcomes. Public Library of Science 2013-12-26 /pmc/articles/PMC3873392/ /pubmed/24386285 http://dx.doi.org/10.1371/journal.pone.0083825 Text en © 2013 van der Walt et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article van der Walt, Anneke Kolbe, Scott C. Wang, Yejun E. Klistorner, Alexander Shuey, Neil Ahmadi, Gelareh Paine, Mark Marriott, Mark Mitchell, Peter Egan, Gary F. Butzkueven, Helmut Kilpatrick, Trevor J. Optic Nerve Diffusion Tensor Imaging after Acute Optic Neuritis Predicts Axonal and Visual Outcomes |
title | Optic Nerve Diffusion Tensor Imaging after Acute Optic Neuritis Predicts Axonal and Visual Outcomes |
title_full | Optic Nerve Diffusion Tensor Imaging after Acute Optic Neuritis Predicts Axonal and Visual Outcomes |
title_fullStr | Optic Nerve Diffusion Tensor Imaging after Acute Optic Neuritis Predicts Axonal and Visual Outcomes |
title_full_unstemmed | Optic Nerve Diffusion Tensor Imaging after Acute Optic Neuritis Predicts Axonal and Visual Outcomes |
title_short | Optic Nerve Diffusion Tensor Imaging after Acute Optic Neuritis Predicts Axonal and Visual Outcomes |
title_sort | optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873392/ https://www.ncbi.nlm.nih.gov/pubmed/24386285 http://dx.doi.org/10.1371/journal.pone.0083825 |
work_keys_str_mv | AT vanderwaltanneke opticnervediffusiontensorimagingafteracuteopticneuritispredictsaxonalandvisualoutcomes AT kolbescottc opticnervediffusiontensorimagingafteracuteopticneuritispredictsaxonalandvisualoutcomes AT wangyejune opticnervediffusiontensorimagingafteracuteopticneuritispredictsaxonalandvisualoutcomes AT klistorneralexander opticnervediffusiontensorimagingafteracuteopticneuritispredictsaxonalandvisualoutcomes AT shueyneil opticnervediffusiontensorimagingafteracuteopticneuritispredictsaxonalandvisualoutcomes AT ahmadigelareh opticnervediffusiontensorimagingafteracuteopticneuritispredictsaxonalandvisualoutcomes AT painemark opticnervediffusiontensorimagingafteracuteopticneuritispredictsaxonalandvisualoutcomes AT marriottmark opticnervediffusiontensorimagingafteracuteopticneuritispredictsaxonalandvisualoutcomes AT mitchellpeter opticnervediffusiontensorimagingafteracuteopticneuritispredictsaxonalandvisualoutcomes AT egangaryf opticnervediffusiontensorimagingafteracuteopticneuritispredictsaxonalandvisualoutcomes AT butzkuevenhelmut opticnervediffusiontensorimagingafteracuteopticneuritispredictsaxonalandvisualoutcomes AT kilpatricktrevorj opticnervediffusiontensorimagingafteracuteopticneuritispredictsaxonalandvisualoutcomes |